# Predicting CSA-AKI With ACTA-PORT Score

> **NCT06484907** · — · COMPLETED · sponsor: **Ankara City Hospital Bilkent** · enrollment: 467 (actual)

## Conditions studied

- Cardiac Disease
- Blood Transfusion
- Acute Kidney Injury

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06484907
- **Lead sponsor:** Ankara City Hospital Bilkent
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-01
- **Primary completion:** 2024-09-15
- **Final completion:** 2024-12-01
- **Target enrollment:** 467 (ACTUAL)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06484907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06484907, "Predicting CSA-AKI With ACTA-PORT Score". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06484907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
